Related Experiment Video
Updated: Jun 23, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus in Utah 2000-2021
Matthew C Hesterman1, Braden S Fallon1, Keisa M Lynch2
1School of Dentistry, University of Utah, Salt Lake City, Utah, USA.
Background:
This study assessed the epidemiology of hepatitis delta virus (HDV) within the University of Utah UHealth health care system (2000-2021).
Methods:
Analysis of HDV/HBV testing, diagnostic codes, liver enzymes, and comorbidities was performed.
Results:
Among the 1962 HBV patients, only 22.2% underwent HDV testing, revealing an 8.3% positivity rate for HDV coinfections. This study observed a consistent increase in HBV and HDV cases, with higher HDV detection rates linked to increased testing. Limited HDV testing and potential screening biases were evident.
Discussion:
Improved HDV testing and surveillance are crucial for early detection and implementation of targeted therapies.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction

